Healthy Skepticism Library
Favourite items of Peter Mansfield
Page 1 of 1 pages
HSL2121
Smith R.
Curbing the Influence of the Drug Industry: A British View.
PLoS Med 2005 Aug 22:(9):e241
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020241
HSL2069
Adair RF, Holmgren LR.
Do drug samples influence resident prescribing behavior? A randomized trial.
Am J Med 2005 Aug118:(8):881-4
http://www.amjmed.com/article/PIIS000293430500197X/fulltext
HSL1695
Zipkin DA, Steinman MA.
Interactions Between Pharmaceutical Representatives and Doctors in Training: A thematic review.
J Gen Intern Med 2005 Jun 1320:(8):777-86
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.0134.x
HSL2036
Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, Henderson KM, Maguire J, Stokes BJ, Macdonald GJ, Day RO.
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.
Med J Aust 2005 Jun 6182:(11):557-60
http://www.mja.com.au/public/issues/182_11_060605/hen10805_fm.html
HSL1646
Brodkey AC.
The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
Acad Psychiatry 2005 Sum29:(2):222-9
http://ap.psychiatryonline.org/cgi/content/full/29/2/222
HSL2070
Freudenberg N.
Public health advocacy to change corporate practices: implications for health education practice and research.
Health Educ Behav 2005 Jun32:(3):298-319
http://heb.sagepub.com/cgi/reprint/32/3/298
HSL1689
Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P.
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
JAMA 2005 Apr 27293:(16):1995-2002
http://jama.ama-assn.org/cgi/content/full/293/16/1995
HSL2035
Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K.
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Intern Med J 2005 Apr35:(4):206-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1444-0903.2004.00799.x
HSL2033
Mansfield PR, Mintzes B, Richards D, Toop L.
Direct to consumer advertising.
BMJ 2005 Jan 1330:(7481):5-6
http://bmj.bmjjournals.com/cgi/content/full/330/7481/5
HSL1
Mansfield P.
Accepting what we can learn from advertising's mirror of desire.
BMJ 2004 Dec 18329:(7480):1487-8
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15604193
HSL2037
Scott T, Stanford N, Thompson DR.
Killing me softly: myth in pharmaceutical advertising.
BMJ 2004 Dec 18329:(7480):1484-7
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15604192
HSL1615
Douglas KM, Sutton RM.
Right about others, wrong about ourselves? Actual and perceived self-other differences in resistance to persuasion
Br J Soc Psychol 2004 Dec43:(Pt 4):585-603
http://www.ingentaconnect.com/content/bpsoc/bjsp/2004/00000043/00000004/art00007?token=005c10cc4e7247444f6d6222346b62687633502b333e3541333c4a2f246c6a38574b675423783c77eefc266e7e60
HSL354
Mansfield PR, Henry D.
Misleading drug promotion--no sign of improvements.
Pharmacoepidemiol Drug Saf 2004 Nov13:(11):797-9
http://www3.interscience.wiley.com/cgi-bin/abstract/107632790/ABSTRACT
HSL366
Sweet M.
Doctors and drug companies are locked in 'vicious circle'.
BMJ 2004 Oct 30329:(7473):998
http://bmj.bmjjournals.com/cgi/content/full/329/7473/998
HSL1157
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May79:(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432
HSL1420
Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
Lancet 2004 Apr 24363:(9418):1341-5
http://linkinghub.elsevier.com/retrieve/pii/S0140673604160431
HSL151
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19180:(8):411-4
http://www.mja.com.au/public/issues/180_08_190404/rog10715_fm.html
HSL1782
Breen KJ.
The medical profession and the pharmaceutical industry: when will we open our eyes?
Med J Aust 2004 Apr 19180:(8):409-10
http://www.mja.com.au/public/issues/180_08_190404/bre10055_fm.html
HSL152
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL.
Efficacy and safety of antidepressants for children and adolescents.
BMJ 2004 Apr 10328:(7444):879-83
http://bmj.com/cgi/content/full/328/7444/879
HSL514
Schafer A.
Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
J Med Ethics 2004 Feb30:(1):8-24
http://jme.bmjjournals.com/cgi/content/full/30/1/8
HSL1147
Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-JunSuppl Web Exclusives:W4-234-45
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.234v1
HSL356
Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb73:(1):10-6
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=PPS2004073001010
HSL1189
Mansfield PR.
Healthy Skepticism's new AdWatch: understanding drug promotion.
Med J Aust 2003 Dec 1-15179:(11-12):644-5
http://www.mja.com.au/public/issues/179_11_011203/man10667_fm.html
HSL859
Katz D, Mansfield P, Goodman R, Tiefer L, Merz J.
Psychological aspects of gifts from drug companies.
JAMA 2003 Nov 12290:(18):2404-5
http://jama.ama-assn.org/cgi/content/full/290/18/2404-b
HSL2066
Dana J, Loewenstein G.
A social science perspective on gifts to physicians from industry.
JAMA 2003 Jul 9290:(2):252-5
http://jama.ama-assn.org/cgi/content/full/290/2/252
HSL423
Mansfield PR.
Bribes for doctors: a gift for bioethicists?
Am J Bioeth 2003 Summer3:(3):47-8
HSL1233
Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ 2003 Apr 29168:(9):1133-7
http://www.cmaj.ca/cgi/content/full/168/9/1133
HSL1227
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The quantity and quality of scientific graphs in pharmaceutical advertisements.
J Gen Intern Med 2003 Apr18:(4):294-7
http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0884-8734&date=2003&volume=18&issue=4&spage=294
HSL2081
Prosser H, Almond S, Walley T.
Influences on GPs' decision to prescribe new drugs-the importance of who says what.
Fam Pract 2003 Feb20:(1):61-8
http://fampra.oxfordjournals.org/cgi/content/full/20/1/61
HSL1176
Villanueva P, Peiro S, Librero J, Pereiro I.
Accuracy of pharmaceutical advertisements in medical journals.
Lancet 2003 Jan 4361:(9351):27-32
http://linkinghub.elsevier.com/retrieve/pii/S0140673603121186
HSL192
Katz D, Caplan AL, Merz JF.
All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Am J Bioeth 20033:(3):39-46
http://www.ingentaconnect.com/content/routledg/ajob/2003/00000003/00000003/art00027
HSL1196
Braithwaite J.
Restorative Justice and Responsive Regulation
Oxford: Oxford University Press 2002
http://www.oup.co.uk/isbn/0-19-515839-3
HSL1893
Brotons C, Moral I, Ribera A, Cascant P, Iglesias M, Permanyer-Miralda G, Ferreira Gonzalez I, Soler-Soler J.
[Methods of reporting research-results and their influence on decision-making by cardiologists prescribing drugs for primary and secondary prevention.]
Rev Esp Cardiol 2002 Oct55:(10):1042-51
http://www.revespcardiol.org/cgi-bin/wdbcgi.exe/cardio/cardioeng.acceso_full.alta
HSL2243
Loke TW, Koh FC, Ward JE.
Pharmaceutical advertisement claims in Australian medical publications.
Med J Aust 2002 Sep 16177:(6):291-3
http://www.mja.com.au/public/issues/177_06_160902/lok10004_fm.html
HSL1611
Sagarin BJ, Cialdini RB, Rice WE, Serna SB.
Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion.
J Pers Soc Psychol 2002 Sep83:(3):526-41
http://content.apa.org/journals/psp/83/3/526
HSL2077
Hall KH.
Reviewing intuitive decision-making and uncertainty: the implications for medical education.
Med Educ 2002 Mar36:(3):216-24
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2923.2002.01140.x
HSL27
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
BMJ 2002324:278-279
http://bmj.bmjjournals.com/cgi/content/full/324/7332/278
HSL31
Choudhry NK, Stelfox HT, Detsky AS
Relationships between authors of clinical practice guidelines and the pharmaceutical industry
JAMA 2002287:612-617
http://jama.ama-assn.org/cgi/content/full/287/5/612
HSL33
Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001 Dec76:(12):1271-1277
http://www.academicmedicine.org/cgi/content/full/76/12/1271
HSL2032
Sackett DL.
Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).
CMAJ 2001 Oct 30165:(9):1226-37
http://www.cmaj.ca/cgi/content/full/165/9/1226
HSL2146
McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS.
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
JAMA 2001 Oct 24-31286:(16):1994-9
http://jama.ama-assn.org/cgi/content/full/286/16/1994
HSL41
Jones MI, Greenfield SM, Bradley CP.
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2001323:378-384
http://bmj.bmjjournals.com/cgi/content/full/323/7309/378
HSL32
Woloshin S, Schwartz LM, Tremmel J, Welch HG
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
Lancet 2001358:1141-1146
http://linkinghub.elsevier.com/retrieve/pii/S0140673601062547
HSL2053
Ainslie G.
Breakdown of Will
Cambridge: Cambridge University Press 2001
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521596947
HSL2099
Norman GR.
The epistemology of clinical reasoning: perspectives from philosophy, psychology, and neuroscience.
Acad Med 2000 Oct75:(10):
http://www.academicmedicine.org/cgi/content/full/75/10/S127?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Norman+G&titleabstract=epistemology&searchid=1124492605605_451&stored_search=&FIRSTINDEX=0&journalcode=acadmed
HSL216
Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB.
Coverage by the news media of the benefits and risks of medications.
N Engl J Med 2000 Jun 1342:(22):1645-50
http://content.nejm.org/cgi/content/full/342/22/1645
HSL1496
Cialdini RB.
Influence: Science and Practice 4th Edn
New York: Allyn & Bacon 2000
http://www.ablongman.com/catalog/academic/product/0,1144,0321011473,00.html
HSL2038
Braithwaite J, Drahos P.
Global business regulation.
Cambridge: Cambridge University Press 2000
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521784999
HSL2054
Sutherland M, Sylvester AK.
Advertising and the Mind of the Consumer 2nd Ed: What works, what doesn't, and why.
Sydney: Allen & Unwin 2000
http://www.allen-unwin.com.au/Shopping/SearchResults.aspx?search=Advertising+and+the+Mind+of+the+Consumer+
HSL2076
Elstein AS.
Heuristics and biases: selected errors in clinical reasoning.
Acad Med 1999 Jul74:(7):791-4
HSL401
Kamat VR, Nichter M.
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India.
Soc Sci Med 1998 Sep47:(6):779-94
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-3T3SS6V-1H&_coverDate=09%2F16%2F1998&_alid=305663279&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=77260eaace668b4e4f2bdc8361b37ee6
HSL380
Roughead EE, Harvey KJ, Gilbert AL.
Commercial detailing techniques used by pharmaceutical representatives to influence prescribing.
Aust N Z J Med 1998 Jun28:(3):306-10
HSL408
Stelfox HT, Chua G, O'Rourke K, Detsky AS.
Conflict of interest in the debate over calcium-channel antagonists.
N Engl J Med 1998 Jan 8338:(2):101-6
http://content.nejm.org/cgi/content/abstract/338/2/101
HSL381
Roughead EE, Gilbert AL, Harvey KJ.
Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?
Int J Health Serv 199828:(2):269-79
HSL1894
Lexchin J.
What information do physicians receive from pharmaceutical representatives?
Can Fam Physician 1997 May43:941-5
HSL2034
Stryer D, Bero LA.
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
J Gen Intern Med 1996 Oct11:(10):575-83
HSL582
Wolfe S.
Drug advertisements that go straight to the hippocampus.
Lancet 1996 Sep 7348:(9028):632
HSL2039
Estes R.
Tyrany of the bottom line: Why corporations make good people do bad things.
San Francisco: Berrett-Koehler 1996
http://www.bkconnection.com/ProdDetails.asp?ID=1881052753&PG=1&Type=BL&PCS=BKP
HSL2068
Barlow J, Møller C.
A complaint is a gift. Using customer feedback as a strategic tool.
San Francisco: Berrett-Koehler 1996
http://www.bkconnection.com/ProdDetails.asp?ID=1881052818&PG=1&Type=RLMa&PCS=BKP
HSL645
Ziegler MG, Lew P, Singer BC.
The accuracy of drug information from pharmaceutical sales representatives.
JAMA 1995 Apr 26273:(16):1296-8
HSL364
Lexchin J.
Deception by design: Pharmaceutical promotion in the Third World
Penang: Consumers International 1995
HSL1455
Bardelay D, Bécel B.
Visits from medical representatives: fine principles, poor practice
Prescrire International 19954:(18):120-122
HSL2067
Ogilvy D.
Ogilvy on advertising.
London: Prion 1995
http://www.randomhouse.com/vintage/catalog/display.pperl?isbn=9780394729039
HSL2093
Branthwaite A, Downing T.
Marketing to doctors - the human factor.
Scrip Magazine 199532-5
HSL6455
Shaughnessy AF, Slawson DC, Bennett JH.
Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion.
J Gen Intern Med 1994 Oct9:(10):563-8
HSL6454
Scott DK, Ferner RE.
'The strategy of desire' and rational prescribing.
Br J Clin Pharmacol 1994 Mar37:(3):217-9
HSL2043
Ayres I, Braithwaite J.
Responsive regulation: Transcending the deregulation debate.
Oxford: Oxford University Press 1992
http://www.oup.co.uk/isbn/0-19-509376-3
HSL1324
Goleman D.
Vital lies, simple truths: The psychology of self-deception.
London: Bloomsbury 1985
http://www.amazon.com/exec/obidos/tg/detail/-/0684831074/103-6888207-0054229?v=glance
HSL2065
Avorn J, Chen M, Hartley R.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
Am J Med 1982 Jul73:(1):4-8
HSL2075
Kahneman D, Slovic P, Tversky A.
Judgment under uncertainty: heuristics and biases.
New York: Cambridge University Press 1982
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521284147
HSL2047
Fischer DH.
Historian's Fallacies: Toward a logic of historical thought.
New York: Harper Torchbooks 1970
http://www.amazon.com/exec/obidos/tg/detail/-/0061315451/002-4340062-2313626?v=glance
HSL2080
Hamblin CL.
Fallacies
London: Methuen 1970
http://www.valepress.com/Fallacies.htm
HSL2060
Talalay P, Editor.
Drugs in Our Society.
Baltimore: John Hopkins Press 1964
http://www.amazon.com/exec/obidos/tg/detail/-/0801806194/qid=1124494429/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books
HSL2041
Hopkins CC.
My Life in Advertising.
Chicago: 1996 reprint by NTC Business Books 1927
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=
HSL2042
Hopkins CC.
Scientific advertising.
Chicago: 1996 reprint by NTC Business Books 1923
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=
HSL693
Locke J.
An essay concerning human understanding
1690
http://etext.library.adelaide.edu.au/l/locke/john/l81u/index.html
HSL692
Aristotle.
Rhetoric.
Date uncertain 350 350 BCE
http://www.public.iastate.edu/~honeyl/Rhetoric/index.html
Page 1 of 1 pages
